跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MegaLive BrevEase Capsule - NPRA Drug Approval Details
Approvals
/
NPRA
/
MegaLive BrevEase Capsule
Approved
STANDARD
MegaLive BrevEase Capsule
MegaLive BioSciences Sdn Bhd
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 28, 2025
Approval ID
55bf97a2f5c57854
Company
MegaLive BioSciences Sdn Bhd
Type
Standard
Approval Details
Approval Id
55bf97a2f5c57854
Drug Approval Npra Name
MegaLive BrevEase Capsule
Product Name
MegaLive BrevEase Capsule
Registration Number
MAL20036046TC
Holder Company Name
MegaLive BioSciences Sdn Bhd
Holder Address
1ST FLOOR, NO.13 JALAN SELASIH, TAMAN SEMARAK 09000 KULIM MALAYSIA
Holder Phone
04-491 8168
Manufacturer Company Name
THE ORIGIN FOODS SDN. BHD.
Manufacturer Address
LOT 1, JALAN INDUSTRI PBP 11 TAMAN PERINDUSTRIAN PUSAT BANDAR PUCHONG 47100 PUCHONG MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL20036046TC
Version
1751614392
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 28, 2025
Approval ID
55bf97a2f5c57854
Type
Standard
Source
Official Source
Back to NPRA Approvals